Literature DB >> 6486499

Regional cerebral glucose utilization during Althesin anesthesia.

D W Davis, R A Hawkins, A M Mans, L S Hibbard, J F Biebuyck.   

Abstract

The effect of Althesin, an anesthetic comprising two steroids, on regional cerebral function was determined by measurement of regional cerebral glucose utilization. Rats were anesthetized with an intravenous dose of 4, 8, or 20 mg total steroid/kg. These doses produced anesthesia for 12, 18, and 37 min, respectively. There were no physiologically significant effects of Althesin (20 mg/kg) on body temperature, blood pH, or blood gases. Blood pressure and heart rate decreased slightly after administration of Althesin. Althesin had a profound effect on glucose consumption in many, but not all, cerebral structures. The forebrain (especially cerebral cortex) was affected most, while the hindbrain was much less so or not at all. This pattern of functional depression is in accord with the minimal effects observed on physiologic variables. The effects of Althesin differ from those of other known anesthetics and suggest a unique mechanism. The possibility of action through naturally occurring steroid receptors is considered.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6486499     DOI: 10.1097/00000542-198410000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

1.  Hearing and memory in anaesthetised patients.

Authors:  J G Jones; K Konieczko
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

2.  Vasomotor and respiratory responses evoked from the dorsolateral periaqueductal grey are mediated by the dorsomedial hypothalamus.

Authors:  Jouji Horiuchi; Lachlan M McDowall; Roger A L Dampney
Journal:  J Physiol       Date:  2009-09-14       Impact factor: 5.182

3.  Actions of propofol on pontine neurons controlling arterial pressure in rats.

Authors:  A V Krassioukov; A W Gelb; L C Weaver
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.